State Street Corp Anavex Life Sciences Corp. Transaction History
State Street Corp
- $2.36 Trillion
- Q1 2025
A detailed history of State Street Corp transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, State Street Corp holds 3,214,256 shares of AVXL stock, worth $34.6 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,214,256
Previous 2,411,929
33.26%
Holding current value
$34.6 Million
Previous $25.9 Million
6.46%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding AVXL
# of Institutions
200Shares Held
31.3MCall Options Held
1.32MPut Options Held
662K-
Black Rock Inc. New York, NY6.39MShares$68.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$55.1 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$21.8 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$11 Million0.83% of portfolio
-
Morgan Stanley New York, NY865KShares$9.32 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $840M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...